Kitty Yale

Corporate Officer/Principal chez AKERO THERAPEUTICS, INC.

Profil

Kitty Yale is currently the Chief Development Officer at Akero Therapeutics, Inc. Prior to this, she worked at Gilead Sciences, Inc. for 17 years as the Vice President-Clinical Operations.
She also worked at Roche Global Development as a Senior Clinical Research & Operations professional.
Yale received her undergraduate degree from Glasgow Caledonian University.

Postes actifs de Kitty Yale

Sociétés	Poste	Début
AKERO THERAPEUTICS, INC.	Corporate Officer/Principal	01/10/2018

Anciens postes connus de Kitty Yale

Sociétés	Poste	Fin
GILEAD SCIENCES, INC.	Corporate Officer/Principal	01/10/2018
Roche Global Development	Corporate Officer/Principal	-

Formation de Kitty Yale

Glasgow Caledonian University

Undergraduate Degree